Eligibility First
NAD+ support is reviewed after medical history, current medication, symptoms, contraindications, and goals are understood.
NAD+ Therapy // Concierge Longevity Support
iMedi helps eligible patients evaluate NAD+ injection treatment and NAD+ IV therapy within a structured care model focused on fatigue, recovery, metabolic health, and longevity support.
NAD+ support is reviewed after medical history, current medication, symptoms, contraindications, and goals are understood.
The program connects NAD+ questions with sleep, fatigue, recovery, metabolic health, stress load, and nutrition.
Gurugram patients can begin with private physician-led assessment and structured follow-up planning.
NAD+ therapy is now one of the most searched longevity support topics among patients exploring energy, recovery, fatigue, metabolic health, and healthy aging. NAD+ stands for nicotinamide adenine dinucleotide, a coenzyme involved in cellular energy metabolism. In public search behavior, patients may use phrases such as NAD therapy India, NAD+ injection treatment, NAD drip, NAD+ IV therapy, or NAD injection Gurugram. iMedi uses those keywords because they reflect real patient language, but the care model is not a menu-style wellness drip model. The first question is whether NAD+ support is medically appropriate for the person asking. A patient’s age, symptoms, medication history, cardiovascular status, kidney health, metabolic risk, hydration, sleep, nutrition, and expectations all matter before any injection or infusion-based support is discussed.
A search for NAD+ injection treatment usually means the patient is looking for something direct and results-oriented. That does not mean the safest answer is to begin treatment immediately. NAD+ injection treatment and NAD+ IV therapy should sit inside a clinical suitability pathway. iMedi reviews the patient’s current health context, whether fatigue is related to sleep debt, stress, nutritional gaps, metabolic dysfunction, medication effects, inflammation, or another medical issue. NAD+ support may be discussed for eligible patients, but it should not replace diagnosis, metabolic review, sleep correction, nutrition planning, or medical treatment where needed. This is why the page connects NAD+ therapy with longevity healthspan, IV therapy, regenerative metabolic health, and medical weight management rather than isolating it as a single intervention.
NAD+ is often marketed aggressively in wellness and anti-aging spaces. iMedi keeps the language more careful. NAD+ is biologically important, but a therapy page should not promise reverse aging, cure fatigue, or guarantee visible transformation. A better question is whether NAD+ support belongs in a broader longevity support therapy plan for a specific patient. That plan may consider sleep, mitochondrial stress, nutrition, exercise tolerance, body composition, inflammation, alcohol use, work stress, and recovery capacity. For some patients, the right next step may be medical weight loss, GLP-1 metabolic care, physiotherapy, or preventive health review. For others, NAD+ may be one supportive discussion inside a supervised care pathway. The goal is to help patients make informed decisions rather than chase isolated treatments.
iMedi’s model is built for patients who want private, physician-led care rather than a walk-in treatment counter. Gurugram patients can begin with an intake conversation, medical review, and suitability assessment. Where clinically appropriate, the care plan may include at-home physician touchpoints, recovery planning, nutrition or hydration guidance, and follow-up. This concierge structure matters because NAD+ therapy is often searched like a product, while real care requires context. The page is designed to rank for NAD+ therapy Gurugram, NAD+ injection treatment, NAD+ IV therapy, NAD therapy India, and longevity support therapy while clearly explaining that eligibility, safety, and physician judgment come first.
NAD+ is nicotinamide adenine dinucleotide, a coenzyme involved in cellular energy metabolism.
No. iMedi treats NAD+ as a physician-reviewed longevity support topic, not a guaranteed anti-aging result.
NAD+ injection treatment should be considered only after medical history, symptoms, current medications, goals, and safety factors are reviewed by a physician.
Medical Board
iMedi programs are anchored by Dr. Ashish Kalla and built for high-trust healthcare decisions where eligibility, monitoring, and clinical judgment matter.
Dr. Ashish Kalla brings 13+ years of internal medicine experience to metabolic, regenerative, and longevity program design.
Programs are structured around medical history, eligibility review, safety monitoring, and clinical follow-up rather than one-off packages.
The Adiposity-Based Chronic Disease framework helps classify weight and metabolic risk through biology, comorbidity, and long-term relapse risk.